European Association for the Study of the Liver (EASL) Steatotic Liver Disease (SLD) Summit 2025

European Association for the Study of the Liver (EASL) Steatotic Liver Disease (SLD) Summit 2025 is organized by European Association for the Study of the Liver (EASL) and will be held from Jan 23 - 25, 2025 at Estoril Convention Center, Estoril, Lisbon, Portugal.

Description:
Steatotic Liver Disease is one of the most significant challenges the hepatology community faces globally, with its impact continuously growing. At the same time, efforts by stakeholders worldwide are also intensifying to curb this pandemic, leading to rapid advances in the field. Since the landmark nomenclature change last year, cardiometabolic risk factors and alcohol have been recognised as primary drivers, opening numerous new avenues for research and innovation, and new hope for people living with SLD.

The first day opens with a session titled “The trajectory of people living with Steatotic Liver Disease: a clinical update and consensus.” This session will feature talks covering aspects from prevention to end-stage disease management, including key stakeholders. Participants will help create a consensus document for holistic management, including pediatric care.

Also on the first day, the summit will host the “Endpoint Conference on ALD and MetALD in Phase 2 and 3 clinical trials“. This conference focuses on improving clinical trial design, execution, and evaluation for ALD and MetALD, aiming to enhance patient outcomes. It will address the progression from fibrosis to decompensated cirrhosis, the use of invasive versus non-invasive tests as endpoints, and the role of MASH methodologies in informing clinical trials for ALD and MetALD.